Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Multicenter Study of the Analgesic Efficacy and Safety of Subcutaneous Administration of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

Category & Conditions:
Immune System Diseases and Conditions
Medicine:
tanezumab
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
A4091057
Open Plain Language Summary Result:Click here